Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
research paper

Indian Pediatr 2020;57:25-33

Normative Data of Infant Pulmonary Function Testing: A Prospective Birth Cohort Study from India


Prawin Kumar, Aparna Mukherjee, Shivani Randev, Kana Ram Jat, Rakesh Lodha and Sushil K Kabra

From Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

Correspondence to: Dr SK Kabra, Professor, Pediatrics Pulmonology Division, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India.
Email: [email protected]

Received: January 18, 2019;
Initial review: July 10, 2019;
Accepted: October 11, 2019.

 

 

Objective: To develop a normal reference range of Infant pulmonary function test (IPFT) indices for Indian children.

Design: Prospective birth cohort study.

Setting: Division of Pediatric Pulmonology of a tertiary-care institute in India from August 2012 to March 2017.

Participants: All neonates born at the institute during the study period were screened for eligibility.

Measurement: IPFT at baseline and every 6-month until 36-months of age.

Main Outcome Measure(s): Tidal breathing flow-volume loop (TBFVL), Rapid thoracoabdominal compression (RTC), and Raised volume RTC (RVRTC) indices at baseline and follow-up.

Results: 310 newborns were enrolled in the cohort; 281 of them (169 male) had completed 36-months of follow-up at the end of the study period. There was no influence of gender on the baseline IPFT indices. Tidal volume per unit body weight (VT/kg) significantly increased from baseline to 36 months of age (P<0.001) while the peak ratio (tPTEF/tE) initially decreased in first 18-months of age (P<0.001), after that returned to the baseline value by 36 months of age. RTC indices did not change significantly from baseline values. In RVRTC, the ratio of forced expiratory volume in 0.5s to forced vital capacity (FEV0.5/FVC) was significantly decreased from baseline to 36 months of age (P=0.002).

Conclusions: Normal values for various IPFT indices for TBFVL, RTC, and RVRTC from neonates to the age of 36-month are provided. These data may be used as normative data for healthy neonates and children of Indian origin.

Keywords: Indices, Rapid thoracoabdominal compression, Tidal breathing flow-volume loop.


W
hile pulmonary function testing (PFT) is well established for older children (>5 years) and adolescents, it is still evolving for use in infants and preschool children [1]. Sophisticated equipments are now commercially available, which can measure pulmonary function even in premature babies [2].

PFT in infants (IPFT) may contribute to a better understanding of the nature and severity of respiratory illness, progression of the disease, and monitoring response to therapy [3]. Serial measurements of lung function since birth, especially in high-risk infants, may be helpful in recognition of early deviation from the normal pattern of lung development. Longitudinal studies have shown that many of the chronic respiratory disorders have their origin in childhood; hence, intervention at this stage may have an impact on the management of the chronic respiratory disease [4,5].

The measurement of PFT in infants and preschool children is a major challenge [6,7]. The values of pulmonary function indices vary with age, sex, body size, and ethnic groups [8,9]. Currently, there is lack of multiethnic global reference range for IPFT indices, so the development of regional ethnicity-specific normative data is the need of the hour, which will definitively expand its use in clinical practice [6].

In this birth cohort, we performed IPFT from birth to 36 months of age. The normative data for various indices were generated, which may be used as reference range in a similar population.

Methods

This prospective birth cohort study was conducted in the Department of Pediatrics of a tertiary-care institute in Delhi, India from August 2012 to March 2017. The study was approved by the Institutional Ethics Committee. Written informed consent was taken from the parents/guardians. All neonates born at the institute during the study period were screened for eligibility. The inclusion criteria were age £4 weeks, full-term (³37 weeks of gestation), and appropriate for gestational age (weight 10th- 90th centile) babies [10]. The exclusion criteria were any perinatal insults (e.g. birth asphyxia, meconium aspiration, any amount of respiratory distress requiring respiratory support, pathological hyperbilirubinemia or seizure), known major congenital birth defect, required parenteral antibiotic or fluid, neonatal cholestasis, chronic kidney disease or inborn error of metabolism, and mother having antepartum or postpartum hemorrhage, preeclampsia or eclampsia, HIV infection, or parents’ refusal for regular follow-up for three years. The enrolled babies were followed-up every 6 months (±8 weeks) and also whenever they had an acute respiratory infection or any other acute condition. The babies were clinically examined, and anthropometric measurements (weight, length, head circumference) were recorded at enrolment and each visit.

The IPFT were performed with Exhalyzer D (Eco Medics AG, Duernten, Switzerland) as per the American Thoracic Society/European Respiratory Society Task Force recommendations [11-16]. IPFT included tidal breathing flow-volume loop (TBFVL), rapid thoracoab-dominal compression (RTC), and raised volume rapid thoracoabdominal compression (RVRTC) maneuvers (Web Fig. 1). All the IPFT maneuvers were performed in the Pediatric Pulmonary Function Laboratory, which is well equipped with a central supply of oxygen and resuscitation equipment. The equipment was calibrated daily for atmospheric temperature and pressure and volume with a 100 mL calibration syringe (M30.9011) provided by the manufacturer. Weight and length/height were recorded using standard methods [17]. IPFT was postponed for 2-4 weeks if the child had an acute respiratory infection.

At enrolment and 6 months of age, IPFT were performed either in awake or natural sleep state after breastfeeding. Beyond six months of age, syrup Triclofos (25-50 mg/kg/dose) was used for sedation, whenever required. The maneuvers were performed in the supine position. Baseline TBFVL was completed within four weeks of birth, while RTC and RVRTC were first performed once the child was ³8 kg as per recommendations of the manufacturer of IPFT equipment. IPFT were repeated at every follow-up visit. The IPFT indices and their physiological interpretation are described in Web Table I.

Statistical analysis: Clinical information during each visit was recorded manually into case record form; data were then entered into Microsoft Access software. IPFT data were automatically stored in software (SPIROWARE, Eco Medics AG, Duernten, Switzerland) after each procedure; data of each individual were extracted and managed in Microsoft Access software. Data were analyzed using Stata software v.13 (Stata Corp, College Station, TX, USA). Quantitative variables were summarized using mean and standard deviation if normally distributed; for skewed distribution, median (interquartile range) was used. Chi-square test was used for the analysis of categorical data. The change in IPFT indices from birth to 36 months of age were calculated with the Wilcoxon sign-rank test. Comparison of IPFT indices between gender and other parameters was analyzed with Wilcoxon rank-sum test (Mann-Whitney Test). A P-value of <0.05 was considered significant. For multivariate analysis, mixed-effects linear regression analysis was performed; IPFT indices were taken as the dependent variable, individual subjects as the random effect and gender, weight, length, and age as fixed effect. The LMS chartmaker Pro (Medical Research Council, UK) was used to model the expected median (µ or M), the coefficient of variation (s or S), and skewness (l or L) and to smooth the centile curves for IPFT indices against age, utilizing the method described by Cole TJ, et al. [18]. The goodness of fit for the model used was tested by the Q curve [18].

Results

A total of 3412 neonates born in our institute from August 2012 to May 2014 were screened for eligibility; 310 neonates fulfilled the inclusion criteria and were enrolled. The median (IQR) age at enrolment was 4th (3rd, 5th) postnatal day. A total of 281 children (90.6%) had completed 36 months of age by 31 March 2017; all IPFT (TBFVL, RTC and RVRTC) at this age were successfully performed in 225 infants (54.5% males) (Fig. 1). The mean (SD) birthweight and length were 2.6 (0.6) kg and 47.7 (6.6) cm, respectively. Other demographic characteristics of enrolled children are summarized in Table I. TBFVL, RTC, and RVRTC were successfully performed in 1705, 948, and 875 occasions (baseline and follow up visits), respectively. The 5th, 25th 50th, 75th, and 95th centile values of TBFVL and RTC as per the age, sex, mean weight and length/height of the enrolled children are described in Table II and III. The same for RVRTC indices are described in Table IV.

TABLE I	Demographic Characteristics of Enrolled Infants (N=310)
Characteristics Values*
Females 141 (45.5)
*Birthweight, g   2648 (689)
*Length, cm 47.7 (6.6)
*Gestation, d 267.9 (22.6)
Mode of delivery
Vaginal  185 (59.6)
Caesarean  101 (32.5)
Instrumental    24 (7.8)
#Age at enrolment, d 4 (3, 5)
Age of parents, y 
Mother 26.5 (3.9)
Father 30.5 (4.3)
Family members in house 5.3 (2.8)
Urban accommodation 277 (89.3)
Smoking at home 93 (30)
Pets at home 31 (10)
Family history of allergy  144 (46.4)
  Asthma 82 (26.5)
  Allergic rhinitis 93 (33.1)
  Atopic dermatitis 32 (10 .3)
All values in no. (%) except *mean (SD) or #median (IQR).

TABLE II Normal Values (Percentiles) of Tidal Breathing Flow Volume Loop Indices

 

TABLE III Normal Values (Percentiles) of Rapid Thoracoabdominal Compression Indices

 

TABLE IV Normal Values of Raised Volume Rapid Thoracoabdominal Compression Indices

Tidal volume (VT) per unit body weight (VT/kg) increased significantly from birth to 36 months of age (P<0.001), which was more prominent in the first 12 months of age (P<0.001). The ratio of time to attained peak expiratory flow to expiratory time (tPTEF/tE) decreased significantly (P<0.001) from baseline till 18 months of age, then it began to increase (P<0.001) to achieve the baseline value at 36 months of age. VPTEF/VE also had decreasing trends from baseline to 18 months (P<0.001) then it gradually increased to achieve the baseline value by 36 months of age. The smoothed centile curves for VT and tPTEF/tE are given in Fig. 2 and 3. At baseline, there was no significant association of gender with IPFT indices. However, on follow up, VT was significantly more in boys at age of 6 months (P<0.001), 12 months (P<0.001), 18 months (P=0.02) and 36 months (P<0.001). The tPTEF/tE was significantly more in girls at 6 months (P=0.004) and 30 months (P=0.04) of age; for other ages it was similar in both sex. VPTEF/VE was significantly greater in girls at 6 months (P=0.004) and 30 months (P=0.02) of age. The tE/ttot was similar in both sexes at all ages.

Fig. 1 Enrolment and follow-up of the study cohort.

 

Fig.2 (a) Change in tidal volume (VT) with age in girls; (b) Change in tidal volume (VT) with age in boys.

 

Fig. 3 (a) Change in ratio of time to attained peak tidal expiratory flow to expiratory time (tPTEF/tE ) with age in girls; (b) Change in ratio of time to attained peak tidal expiratory flow to expiratory time (tPTEF/tE ) with age in boys.

 

Fig. 4 (a) Change in maximum expiratory flow at functional residual capacity (V¢max,FRC ) with age in girls; (b) Change in maximum expiratory flow at functional residual capacity (V¢max,FRC ) with age in boys.

In RTC, V¢maxFRC, V¢50, and V¢70 did not significantly differ from baseline to 36 months of age, while VPEF gradually increased from baseline to 36 months of age (P<0.001). The smoothed centile curves for V¢maxFRC are presented in Fig. 4. V¢max,FRC, V¢50, V¢70, and VPEF were similar in both sexes at all ages except at 30 months, where V¢70 (P=0.01) and VPEF (P<0.001) were significantly higher in boys. In RVRTC, there were minor increases in FVC, FEV0.5, FEF25-75, and MEF25 from baseline till 24 months of age; after that, there were significant increases till 36 months of age (P<0.01).

Fig. 5 (a) Change in forced expiratory volume in 0.5 sec (FEV0.5 ) with age in girls; (b) Change in forced expiratory volume in 0.5 sec (FEV0.5 ) with age in boys.

PEF initially decreased from baseline to 12 months of age (P<0.001) then remained constant till 24-months of age, increasing again till 36 months of age (P<0.001). FEV0.5/FVC was significantly decreased from baseline to 36-months of age (P=0.002), more during baseline to 18 months of age (P<0.001). The smoothed centile curves for FEV0.5 and FVC are represented in Fig. 5 and 6.

Fig.6 Change in forced vital capacity (FVC) with age.

RVRTC indices were similar in both sexes at all ages except at 36-months, where FEV, MEF25, FEF25-75, FEV0.5 and PEF, were significantly higher in boys (P=0.04, 0.01, 0.01, <0.001 and 0.02, respectively). FEV0.5/FVC remained similar in both sexes at all ages.

On multivariate analysis, length/height, body weight, gender, and age were significantly associated with VT. tPTEF/tE was significantly associated with gender, with values at any point being higher for females in comparison to males, after adjusting length/height and bodyweight.

Discussion

IPFT is now widely used in the research context; however, its use in a clinical setting is still restricted by the non-availability of regional and ethnicity-specific reference values. In this prospective birth cohort study, we obtained normative data for TBFVL for neonates to 36 months of age, and RTC and RVRTC from 6 months to 36 months of age.

The major limitation of this study is that subjects were recruited from a single center, which may not be truly representative of the entire population. However, being a tertiary-care institute, subjects were referred from all around the country. Another limitation is that neonates with a family history of smoking or allergy were not excluded in this study, as we considered that they would be normally distributed, though to a different extent, in any given population.

The major strength of this study is the meticulously planned prospective birth cohort design of the study with frequent and regular follow-up. IPFT were performed as per ATS/ERS recommendation. Until one year of age, in the majority of the infants, TBFVL were performed without sedation. As there was a significant difference between genders at a particular age, so gender-specific data have also been presented. Centile curves have been constructed using the LMS method.

In comparison to studies on Caucasian population, VT/kg was markedly lower at baseline in this cohort; however, it gradually increased with age, and by 12 months it became comparable to global values [19,20]. The rest of the TBFVL indices at baseline were comparable with other studies [19-21]. In this cohort, tPTEF/tE and VPTEF/VE were highest at baseline and then gradually decreased until 18 months of age. A study from Switzerland in 342 infants had also observed that tPTEF/tE gradually decreased in the first year of life [20]. However, a prospective birth cohort study from Taiwan did not observe any significant change in VT, tPTEF/tE and VPTEF/VE from 5 to 26 months of follow-up [7]. Furthermore, in the present study, there was no significant influence of gender at baseline IPFT indices; however, on follow up, many of these indices varied significantly with gender. A study from Norway did not find any significant influence of gender on the baseline tidal expiratory volume; however, they observed that tidal flow and flow ratio were significantly higher in males in comparison to female babies [21]. Another study from Taiwan also did not observe any sex-related difference in IPFT indices [7]. V¢max,FRC in this cohort remained similar throughout the follow-up period with no influence of gender. Studies from Taiwan [7], US [22], and a multicentric study from London, Indianapolis, and Boston [23] had observed that V¢max,FRC correlates significantly with the height of the children. The measurement of V¢max,FRC depends on accurate determination of FRC as a volume landmark, which is highly variable, especially in younger children, and this is a significant limitation in RTC measurement [24]. In this study, jacket pressure was kept fixed at 10 kPa while in other studies, it was used in the incremental range from 2-10 kPa [22,25]. Hence, it might be responsible for the deviation of our finding for V¢max,FRC with age from other studies.

In this cohort, most of the RVRTC indices viz., FVC, FEV0.5, FEF25-75, MEF25 and PEF increased minimally until 24 months of age, after that they increased dramatically with age. FEV0.5/FVC decreased from baseline until 36 months of age. There was no gender difference in any of the RVRTC indices except at 36 months where it was more significant in boys. A multicentric study from Indiana and Ohio [25] in children from 3 to 149 weeks had also observed that RVRTC indices were highly correlated with growth (height) of the child while FEV0.5/FVC decreased with increasing length. They also did not find any influence of gender on RVRTC indices except for FEF75, which was higher in girls [26]. Another study from London has documented that RVRTC indices increase with age [25].

In conclusion, this prospective birth cohort study provides reference values for various IPFT indices from neonates to 36 months of age. The median and centile values for boys and girl have been separately provided. Despite some limitation, the data will be useful as a reference range for Indian children for TBFVL, RTC, and RVRTC. These results will serve as normative data for neonates and preschool children of Indian origin.

Acknowledgments: Satish Thomas, Ritu Dubey and Rajat Prakash for their contribution in this study.

Contributors: SKK, RL: conceptualized and designed the study, developed protocol and drafted the manuscript; PK,SR: enrolled patients, collected and analysed data, reviewed literature and prepared initial draft of the manuscript; AM: collected and analysed data, reviewed literature and manuscript preparation; KRJ: data analysis, reviewed literature and manuscript preparation. All authors critically revised and approved the final version of the manuscript.

Funding: The Department of Biotechnology, Government of India.

Competing interests: None stated.


What is Already Known?

• Infant pulmonary function test (IPFT) can help in the understanding of natural course and progression of respiratory disease and monitor the response to therapy in infants and preschool children.

What this Study Adds?

• This study provides the normative data of IPFT indices in healthy Indian children, and the data can be used as reference range for infant pulmonary function test in Indian infant and preschool children.

References

1. Vogt B, Falkenberg C, Weiler N, Frerichs I. Pulmonary function testing in children and infants. Physiol Meas. 2014;35:R59-90.

2. Dinwiddie R. Lung function testing in infants. Allergol Immunopathol (Madr). 2010;38:337-40.

3. Frey U. Clinical applications of infant lung function testing: Does it contribute to clinical decision making? Paediatr Respir Rev. 2001;2:126-30.

4. Baraldi E, Filippone M. Chronic Lung Disease after Premature Birth. N Engl J Med. 2008;358:743-46.

5. Sly PD, Bush A. From the cradle to the grave: The early-life origins of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;193:1-2.

6. Merkus PJFM, Jongste JCD, Stocks J. Respiratory function measurements in infants and children. Eur Respir Monogr. 2005;31:166-94.

7. Lai SH, Liao SL, Yao TC, Tsai MH, Hua MC, Yeh KW, et al. Respiratory function in healthy taiwanese infants: Tidal breathing analysis, passive mechanics, and tidal forced expiration. PLoS One. 2015;10:1-13.

8. Kirkby J, Bonner R, Lum S, Bates P, Morgan V, Strunk RC, et al. Interpretation of pediatric lung function: Impact of ethnicity. Pediatr Pulmonol. 2013;48:20-6.

9. Koopman M, Zanen P, Kruitwagen CLJJ, Van Der Ent CK, Arets HGM. Reference values for paediatric pulmonary function testing: The Utrecht dataset. Respir Med. 2011;105:15-23.

10. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics.1966; 37:403-8.

11. Frey U, Stocks J, Coates A, Sly P, Bates J. Specifications for Equipment Used for Infant Pulmonary Function Testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000;16:731-40.

12. Sly PD, Tepper R, Henschen M, Gappa M, Stocks J. Tidal Forced Expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000;16:741-48.

13. Frey U, Stocks J, Sly P, Bates J, Force T, Ats ERS. Specification for signal processing and data handling used for infant pulmonary function testing. Eur Respir J. 2000;16:1016-22.

14. Bates JHT, Schmalisch G, Filbrun D, Stocks J. Tidal breath analysis for infant pulmonary function testing. Eur Respir J. 2000;16:1180-92.

15. American Thoracic Society/European Respiratory Society. Respiratory Function Measurements in Infants: Measurement Conditions. Am J Respir Crit Care Med. 1995;151:2058-64.

16. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HGM, Aurora P, et al. An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children. Am J Respir Crit Care Med. 2007;175:1304-45.

17. Willis TA, Aspinall BS Nichola MB. Preventing child obesity: A long-term evaluation of the HENRY approach. Community Pract. 2013;86:23-7.

18. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990;44:45-60.

19. Lodrup-Carlsen KC, Carlsen KH. Lung function in awake healthy infants: The first five days of life. Eur Respir J. 1993;6:1496-500.

20. Fuchs O, Latzin P, Thamrin C, Stern G, Frischknecht P, Singer F, et al. Normative data for lung function and exhaled nitric oxide in unsedated healthy infants. Eur Respir J. 2011;37:1208-16.

21. Lodrup Carlsen KC, Magnus P, Carlsen KH. Lung function by tidal breathing in awake healthy newborn infants. Eur Respir J. 1994;7:1660-8.

22. Colin AA, Rao JS, Chen XC, Hunter JM, Hanrahan J, Hiatt P, et al. Forced expiratory flow in uninfected infants and children born to HIV-infected mothers. Am J Respir Crit Care Med. 2001;163:865-73.

23. Hoo A, Dezateux C, Hanrahan JP, Cole TJ, Tepper RS, Stocks J. Sex-specific prediction equations for Vmax (FRC) in infancy: a multicenter collaborative study. Am J Respir Crit Care Med. 2002;165:1084-92.

24. Henschen M, Stocks J. Assessment of airway function using partial expiratory flow-volume curves: How reliable are measurements of maximal expiratory flow at FRC during early infancy? Am J Respir Crit Care Med. 1999;159:480-6.

25. Hoo AF, Lum SY, Goetz I, Dezateux C, Stocks J. Influence of jacket placement on respiratory compliance during raised lung volume measurements in infants. Pediatr Pulmonol. 2001;31:51-8.

26. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, et al. Forced expiratory flows and volumes in infants: Normative data and lung growth. Am J Respir Crit Care Med. 2000;161:353-9.

 

Copyright © 1999-2019 Indian Pediatrics